These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 8783322)

  • 1. Enhanced effects of co-administered dexamethasone and diclofenac on inflammatory pain processing and associated spinal c-Fos expression in the rat.
    Buritova J; Honoré P; Chapman V; Besson JM
    Pain; 1996 Mar; 64(3):559-568. PubMed ID: 8783322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrageenan oedema and spinal Fos-LI neurones are reduced by piroxicam in the rat.
    Buritova J; Honoré P; Chapman V; Besson JM
    Neuroreport; 1995 Jul; 6(10):1385-8. PubMed ID: 7488730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The contribution of GABAB receptor-mediated events to inflammatory pain processing: carrageenan oedema and associated spinal c-Fos expression in the rat.
    Buritova J; Chapman V; Honoré P; Besson JM
    Neuroscience; 1996 Jul; 73(2):487-96. PubMed ID: 8783264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketoprofen produces profound inhibition of spinal c-Fos protein expression resulting from an inflammatory stimulus but not from noxious heat.
    Buritova J; Honoré P; Besson JM
    Pain; 1996 Oct; 67(2-3):379-89. PubMed ID: 8951933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The contribution of NMDA receptor activation to spinal c-Fos expression in a model of inflammatory pain.
    Chapman V; Honoré P; Buritova J; Besson JM
    Br J Pharmacol; 1995 Sep; 116(1):1628-34. PubMed ID: 8564229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraplantar morphine depresses spinal c-Fos expression induced by carrageenin inflammation but not by noxious heat.
    Honoré P; Buritova J; Besson JM
    Br J Pharmacol; 1996 Jun; 118(3):671-80. PubMed ID: 8762093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction of carrageenin oedema and the associated c-Fos expression in the rat lumbar spinal cord by nitric oxide synthase inhibitor.
    Honoré P; Chapman V; Buritova J; Besson JM
    Br J Pharmacol; 1995 Jan; 114(1):77-84. PubMed ID: 7536097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral and/or central effects of racemic-, S(+)- and R(-)-flurbiprofen on inflammatory nociceptive processes: a c-Fos protein study in the rat spinal cord.
    Buritova J; Besson JM
    Br J Pharmacol; 1998 Sep; 125(1):87-101. PubMed ID: 9776348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological contributions of neurokinin 1 receptor activation, and interactions with NMDA receptors, to inflammatory-evoked spinal c-Fos expression.
    Chapman V; Buritova J; Honoré P; Besson JM
    J Neurophysiol; 1996 Sep; 76(3):1817-27. PubMed ID: 8890294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent reduction of inflammation and spinal Fos-LI neurons by systemic diclofenac in the rat.
    Buritova J; Honoré P; Chapman V; Besson JM
    Neurosci Lett; 1995 Mar; 188(3):175-8. PubMed ID: 7609902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin and acetaminophen reduced both Fos expression in rat lumbar spinal cord and inflammatory signs produced by carrageenin inflammation.
    Honoré P; Buritova J; Besson JM
    Pain; 1995 Dec; 63(3):365-375. PubMed ID: 8719538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. UP 202-56, an adenosine analogue, selectively acts via A1 receptors to significantly decrease noxiously-evoked spinal c-Fos protein expression.
    Honoré P; Buritova J; Chapman V; Besson JM
    Pain; 1998 Apr; 75(2-3):281-93. PubMed ID: 9583764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-related anti-inflammatory/analgesic effects of lornoxicam: a spinal c-Fos protein study in the rat.
    Buritova J; Besson JM
    Inflamm Res; 1998 Jan; 47(1):18-25. PubMed ID: 9495582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The contribution of peripheral bradykinin B2 receptors to carrageenan-evoked oedema and spinal c-Fos expression in rats.
    Buritova J; Chapman V; Honoré P; Besson JM
    Eur J Pharmacol; 1997 Feb; 320(1):73-80. PubMed ID: 9049605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potent anti-inflammatory/analgesic effects of lornoxicam in comparison to other nsaids: a c-fos study in the rat.
    Buritova J; Besson JM
    Inflammopharmacology; 1997; 5(4):331-41. PubMed ID: 17657612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To what extent do spinal interactions between an alpha-2 adrenoceptor agonist and a mu opioid agonist influence noxiously evoked c-Fos expression in the rat? A pharmacological study.
    Honoré P; Chapman V; Buritova J; Besson JM
    J Pharmacol Exp Ther; 1996 Jul; 278(1):393-403. PubMed ID: 8764375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of U-69,593, a kappa-opioid receptor agonist, on carrageenin-induced peripheral oedema and Fos expression in the rat spinal cord.
    Catheline G; Le Guen S; Besson JM
    Eur J Pharmacol; 1999 Apr; 370(3):287-96. PubMed ID: 10334505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrageenin-evoked c-Fos expression in rat lumbar spinal cord: the effects of indomethacin.
    Honoré P; Buritova J; Besson JM
    Eur J Pharmacol; 1995 Jan; 272(2-3):249-59. PubMed ID: 7713169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective cyclooxygenase-2 inhibition reduces carrageenan oedema and associated spinal c-Fos expression in the rat.
    Buritova J; Chapman V; Honoré P; Besson JM
    Brain Res; 1996 Apr; 715(1-2):217-20. PubMed ID: 8739641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antinociceptive effects of RB101(S), a complete inhibitor of enkephalin-catabolizing enzymes, are enhanced by (+)-HA966, a functional NMDA receptor antagonist: a c-Fos study in the rat spinal cord.
    Buritova J; Le Guen S; Fournié-Zaluski MC; Roques BP; Besson JM
    Eur J Pain; 2003; 7(3):241-9. PubMed ID: 12725847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.